NancyChanMD

Breast Cancer

Director, Breast Cancer Clinical Research

Dr. Chan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2011 - 2014
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2008 - 2011
Stony Brook University Health Sciences Center School of MedicineClass of 2008

PubMed

108 citations
First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors
Mark N. Stein, Joseph R. Bertino, Howard L. Kaufman, Tina M. Mayer, Rebecca A. Moss
Clinical Cancer Research. 2017-08-01
149 citations
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer.
Anshuman Panda, Janice M. Mehnert, Kim M. Hirshfield, Greg Riedlinger, Sherri Damare
Journal of the National Cancer Institute. 2018-03-01
129 citations
Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.
M Palmeri, J Mehnert, A W Silk, S K Jabbour, S Ganesan
ESMO Open. 2022-02-01

Lectures

A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Perlmutter Cancer Center Medical Oncologist Advances Innovative Clinical Trials for Breast CancerFebruary 23rd, 2022
New Hope on the Horizon for Triple-Negative Breast Cancer Patients: Cleveland Clinic Launches Phase 1 Clinical Trial for TNBC VaccineOctober 26th, 2021
Rutgers Cancer Institute of New Jersey Experts Available for Comment on General Breast Cancer Topics During Virtual San Antonio Breast Cancer Symposium (SABCS)December 7th, 2020
Join now to see all